Clinical Trial Update: Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the CryoCor Cardiac Cryoablation System for atrial flutter has completed, with safety and efficacy data to be reported by th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Flutter

Drugs mentioned

• CryoCor Cardiac Cryoablation System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Flutter | Phase 3 | Status: COMPLETED